Itami, Japan

Masaaki Kuwahara


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1992-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masaaki Kuwahara: Innovator in Pharmaceutical Chemistry

Introduction

Masaaki Kuwahara is a notable inventor based in Itami, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on imidazopyridazine compounds. With a total of two patents to his name, Kuwahara's inventions focus on compounds that possess valuable therapeutic properties.

Latest Patents

Kuwahara's latest patents include the development of imidazopyridazine compounds that exhibit antiallergic, anti-inflammatory, and anti-PAF activities. These compounds are characterized by specific structural formulas where R1 can be a hydrogen or halogen atom, or a lower alkyl group with possible substituents. R2 and R3 can independently be a hydrogen atom, a lower alkyl group, a cycloalkyl group, or a phenyl group, with the potential to form heterocyclic rings. The compounds also include their pharmaceutically acceptable salts, which are crucial for their production and use in medical applications.

Career Highlights

Masaaki Kuwahara is currently associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has allowed him to focus on the development of innovative therapeutic agents that address various health issues. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.

Collaborations

Kuwahara has collaborated with notable colleagues such as Akio Miyake and Hisashi Kuriki. These collaborations have fostered a productive environment for research and development, leading to advancements in the field of pharmaceutical sciences.

Conclusion

Masaaki Kuwahara's contributions to pharmaceutical chemistry through his patents on imidazopyridazine compounds highlight his innovative spirit and dedication to improving health outcomes. His work continues to influence the development of new therapeutic agents in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…